Pseudomonas aeruginosa is associated with several human infections, mainly related to
healthcare services. In the hospital, it is associated with resistance to several antibiotics …

The genus Pseudomonas described in 1894 is one of the most diverse and ubiquitous
bacterial genera which encompass species isolated worldwide. In the last years more than …

Background Carbapenemase production is a global public health threat. Antimicrobial
resistance (AMR) data analysis is critical to public health policy. Here we analyzed …

Introduction Carbapenemases are β-lactamases able to hydrolyze a wide range of β-lactam
antibiotics, including carbapenems. Carbapenemase production in Enterobacterales …

Pseudomonas aeruginosa is a high-priority bacterial agent that causes healthcare-acquired
infections (HAIs), which often leads to serious infections and poor prognosis in vulnerable …

Antimicrobial resistance (AMR) is a major public health threat of global proportions, which
has the potential to lead to approximately ten million deaths per year by 2050. Pressured by …

Pseudomonas aeruginosa (PA), a nonlactose fermenting gram-negative bacillus, is a
common cause of nosocomial infections in critically ill or debilitated patients, particularly …

Objectives The proliferation of metallo-β-lactamase (MBL)-producing Pseudomonas
aeruginosa represents a significant public health threat. P. aeruginosa undergoes significant …

Pseudomonas aeruginosa is one of the six antimicrobial-resistant pathogens known as
“ESKAPE” that represent a global threat to human health and are considered priority targets …

Pseudomonas aeruginosa (PA), a non–lactose-fermenting gram-negative bacillus, is a
common cause of nosocomial infections in critically ill or debilitated patients, particularly …